National Health Investors, Inc.

  • Market Cap: Small Cap
  • Industry: Realty
  • ISIN: US63633D1046
USD
71.44
2.01 (2.9%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationQuarterly Results
Results Snapshot
YoYQoQ
Figures in Million
Consolidate Quarterly Results
Mar'26
Dec'25
Sep'25
Jun'25
Mar'25
Dec'24
Sep'24
Net Sales
115.86
106.55
90.57
91.39
90.02
86.48
83.67
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
115.86
106.55
90.57
91.39
90.02
86.48
83.67
Raw Material Cost
30.97
26.00
18.86
13.31
13.74
13.60
13.53
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
15.04
14.26
13.77
15.00
14.34
15.24
14.94
Selling and Distribution Expenses
5.61
6.64
5.33
5.05
4.27
4.75
4.14
Other Expenses
1.18
0.94
0.84
0.70
0.84
0.49
0.43
Total Expenditure (Excl Depreciation)
63.45
56.30
46.36
40.32
40.72
38.52
36.91
Operating Profit (PBDIT) excl Other Income
52.400000000000006
50.199999999999996
44.2
51.1
49.3
48
46.8
Other Income
2.65
1.77
0.19
1.63
0.53
11.22
0.10
Operating Profit (PBDIT)
79.46
74.40
65.34
73.34
69.71
78.59
65.35
Interest
15.04
14.26
13.77
15.00
14.34
15.24
14.94
Exceptional Items
-0.26
0.05
1.84
-1.01
-1.68
-1.16
-3.67
Gross Profit (PBDT)
60.47
58.17
50.77
57.43
56.40
53.47
51.65
Depreciation
24.42
22.38
20.94
20.64
19.88
19.41
18.49
Profit Before Tax
39.75
37.80
32.48
36.69
33.82
42.79
28.24
Tax
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
40.02
38.16
32.86
36.99
34.16
43.24
28.54
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
40.02
38.16
32.86
36.99
34.16
43.24
28.54
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
-0.35
-0.36
-0.38
-0.30
-0.35
-0.46
-0.30
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
39.67
37.80
32.48
36.69
33.82
42.79
28.24
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
0.01
0.01
0.01
0.01
0.01
0.01
0.01
Reserves
1,514.78
1,521.54
1,480.90
1,479.64
1,426.47
1,366.47
1,228.95
Earnings per share (EPS)
0.82
0.8
0.69
0.79
0.74
0.95
0.65
Diluted Earnings per share
0.82
0.8
0.69
0.79
0.74
0.95
0.65
Operating Profit Margin (Excl OI)
45.23%
47.16%
48.81%
55.88%
54.77%
55.46%
55.88%
Gross Profit Margin
55.39%
56.48%
58.98%
62.74%
59.65%
71.91%
55.86%
PAT Margin
34.55%
35.82%
36.28%
40.47%
37.95%
50.0%
34.11%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Quarterly Analysis Highlights - QoQ
stock-summary

Net Sales

QoQ Growth in quarter ended Mar 2026 is 8.83% vs 17.55% in Dec 2025

stock-summary

Consolidate Net Profit

QoQ Growth in quarter ended Mar 2026 is 5.03% vs 16.31% in Dec 2025

stock-summary

Operating Profit (PBDIT) excl Other Income

QoQ Growth in quarter ended Mar 2026 is 5.79% vs 11.35% in Dec 2025

stock-summary

Interest

QoQ Growth in quarter ended Mar 2026 is 4.90% vs 3.62% in Dec 2025

stock-summary

Operating Profit Margin (Excl OI)

QoQ Growth in quarter ended Mar 2026 has fallen from Dec 2025

Compare Quarterly Results Of National Health Investors, Inc. With
Markets Mojo
Figures in Million
Consolidate Quarterly Results
Markets Mojo
Markets Mojo
Change(USD)
Change(%)
Net Sales
115.86
254.42
-138.56
-54.46%
Other Operating Income
0.00
0.00
0.00
Total Operating income
115.86
254.42
-138.56
-54.46%
Raw Material Cost
30.97
110.31
-79.34
-71.92%
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
0.00
0.00
0.00
Power Cost
0
0
0.00
Manufacturing Expenses
15.04
69.70
-54.66
-78.42%
Selling and Distribution Expenses
5.61
22.79
-17.18
-75.38%
Other Expenses
1.18
2.17
-0.99
-45.62%
Total Expenditure (Excl Depreciation)
63.45
224.48
-161.03
-71.73%
Operating Profit (PBDIT) excl Other Income
52.40
29.94
22.46
75.02%
Other Income
2.65
-2.48
5.13
206.85%
Operating Profit (PBDIT)
79.46
97.21
-17.75
-18.26%
Interest
15.04
69.70
-54.66
-78.42%
Exceptional Items
-0.26
-35.16
34.90
99.26%
Gross Profit (PBDT)
60.47
74.36
-13.89
-18.68%
Depreciation
24.42
69.75
-45.33
-64.99%
Profit Before Tax
39.75
-77.40
117.15
151.36%
Tax
0.00
0.00
0.00
Provisions and contingencies
0
0
0.00
Profit After Tax
40.02
-78.78
118.80
150.80%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
40.02
-78.78
118.80
150.80%
Share in Profit of Associates
0
0
0.00
Minority Interest
-0.35
1.06
-1.41
-133.02%
Other related items
0.00
0.00
0.00
Consolidated Net Profit
39.67
-77.72
117.39
151.04%
Equity Capital
0
0
0.00
Face Value
0.01
0.01
0.00
Reserves
1,514.78
3,314.39
-1,799.61
-54.30%
Earnings per share (EPS)
0.82
-1.20
2.02
168.33%
Diluted Earnings per share
0.82
-1.20
2.02
168.33%
Operating Profit Margin (Excl OI)
45.23%
11.77%
0.00
33.46%
Gross Profit Margin
55.39%
-3.01%
0.00
58.40%
PAT Margin
34.55%
-30.96%
0.00
65.51%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Quarterly - Net Sales
Net Sales 11.59 Million
in Mar 2026

Figures in Million
stock-summary

QoQ Growth in quarter ended Mar 2026 is 8.83% vs 17.55% in Dec 2025

stock-summary

YoY Growth in quarter ended Mar 2026 is 28.78% vs 9.49% in Mar 2025

Quarterly - Consolidate Net Profit
Consolidate Net Profit 3.97 Million
in Mar 2026

Figures in Million
stock-summary

QoQ Growth in quarter ended Mar 2026 is 5.03% vs 16.31% in Dec 2025

stock-summary

YoY Growth in quarter ended Mar 2026 is 17.46% vs 10.10% in Mar 2025

Quarterly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 7.68 Million
in Mar 2026

Figures in Million
stock-summary

QoQ Growth in quarter ended Mar 2026 is 5.79% vs 11.35% in Dec 2025

stock-summary

YoY Growth in quarter ended Mar 2026 is 10.98% vs 8.63% in Mar 2025

Quarterly - Interest
Interest 1.50 Million
in Mar 2026

Figures in Million
stock-summary

QoQ Growth in quarter ended Mar 2026 is 4.90% vs 3.62% in Dec 2025

stock-summary

YoY Growth in quarter ended Mar 2026 is 4.90% vs -4.03% in Mar 2025

Quarterly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 45.23%
in Mar 2026

Figures in %
stock-summary

QoQ Growth in quarter ended Mar 2026 has fallen from Dec 2025

stock-summary

YoY Growth in quarter ended Mar 2026 has fallen from Mar 2025